Literature DB >> 10411551

Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits.

P Witting1, K Pettersson, A M Ostlund-Lindqvist, C Westerlund, M Wâgberg, R Stocker.   

Abstract

Antioxidants can inhibit atherosclerosis, but it is unclear how inhibition of intimal lipid oxidation relates to atherogenesis. Here we tested the effect of probucol and its metabolite bisphenol on aortic lipid (per)oxidation and atherogenesis in Watanabe heritable hyperlipidemic (WHHL) rabbits. LDL and aortas from rabbits fed probucol contained bisphenol at concentrations comparable to those in bisphenol-treated animals. Bisphenol treatment increased plasma cholesterol slightly, and plasma and aortic alpha-tocopherol more substantially; these parameters were unaffected by probucol. Bisphenol and probucol treatment both enhanced the resistance of circulating LDL to peroxyl radical-induced lipid peroxidation; this was due to bisphenol, not probucol. Only probucol enhanced LDL's resistance to Cu(2+)-induced oxidation. Both bisphenol and probucol treatment strongly inhibited aortic accumulation of hydroperoxides and hydroxides of cholesteryl esters and triglycerides [LO(O)H]. Despite this, however, probucol had a modestly significant effect on the extent of lesion formation; bisphenol had no inhibitory effect. In addition, the extent of atherosclerosis did not correlate with amounts of aortic LO(O)H present, but, as expected, it did correlate with aortic alpha-tocopherol and cholesterol. Together, these results suggest that aortic accumulation of LO(O)H is not required for, nor is alpha-tocopherol depleted during, the initiation and progression of atherogenesis in WHHL rabbits.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411551      PMCID: PMC408476          DOI: 10.1172/JCI6391

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  Ex vivo lipopolysaccharide-induced interleukin-1 secretion from murine peritoneal macrophages inhibited by probucol, a hypocholesterolemic agent with antioxidant properties.

Authors:  G Ku; N S Doherty; L F Schmidt; R L Jackson; R J Dinerstein
Journal:  FASEB J       Date:  1990-04-01       Impact factor: 5.191

3.  Probucol inhibits oxidative modification of low density lipoprotein.

Authors:  S Parthasarathy; S G Young; J L Witztum; R C Pittman; D Steinberg
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

4.  Concentration-dependent antioxidant activity of probucol in low density lipoproteins in vitro: probucol degradation precedes lipoprotein oxidation.

Authors:  R L Barnhart; S J Busch; R L Jackson
Journal:  J Lipid Res       Date:  1989-11       Impact factor: 5.922

5.  Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N'-diphenyl-phenylenediamine.

Authors:  C P Sparrow; T W Doebber; J Olszewski; M S Wu; J Ventre; K A Stevens; Y S Chao
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

6.  Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.

Authors:  T Kita; Y Nagano; M Yokode; K Ishii; N Kume; A Ooshima; H Yoshida; C Kawai
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

7.  Continuous monitoring of in vitro oxidation of human low density lipoprotein.

Authors:  H Esterbauer; G Striegl; H Puhl; M Rotheneder
Journal:  Free Radic Res Commun       Date:  1989

8.  The antioxidant butylated hydroxytoluene protects against atherosclerosis.

Authors:  I Björkhem; A Henriksson-Freyschuss; O Breuer; U Diczfalusy; L Berglund; P Henriksson
Journal:  Arterioscler Thromb       Date:  1991 Jan-Feb

9.  Attenuation of atherosclerosis in a modified strain of hypercholesterolemic Watanabe rabbits with use of a probucol analogue (MDL 29,311) that does not lower serum cholesterol.

Authors:  S J Mao; M T Yates; R A Parker; E M Chi; R L Jackson
Journal:  Arterioscler Thromb       Date:  1991 Sep-Oct

10.  Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.

Authors:  S Ylä-Herttuala; W Palinski; M E Rosenfeld; S Parthasarathy; T E Carew; S Butler; J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

View more
  6 in total

1.  Is lipid peroxidation relevant to atherogenesis?

Authors:  J W Heinecke
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

Review 2.  Cellular cofactors for amyloid beta-peptide-induced cell stress. Moving from cell culture to in vivo.

Authors:  S D Yan; A Roher; A M Schmidt; D M Stern
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

3.  Selenium inhibits renal oxidation and inflammation but not acute kidney injury in an animal model of rhabdomyolysis.

Authors:  Anu Shanu; Ludwig Groebler; Hyun Bo Kim; Sarah Wood; Claire M Weekley; Jade B Aitken; Hugh H Harris; Paul K Witting
Journal:  Antioxid Redox Signal       Date:  2012-10-16       Impact factor: 8.401

4.  Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging.

Authors:  Ben J Wu; Krishna Kathir; Paul K Witting; Konstanze Beck; Katherine Choy; Cheng Li; Kevin D Croft; Trevor A Mori; David Tanous; Mark R Adams; Antony K Lau; Roland Stocker
Journal:  J Exp Med       Date:  2006-04-10       Impact factor: 14.307

5.  Serum Amyloid A Stimulates Vascular and Renal Dysfunction in Apolipoprotein E-Deficient Mice Fed a Normal Chow Diet.

Authors:  Belal Chami; Farjaneh Hossain; Thomas W Hambly; Xiaoping Cai; Roshanak Aran; Genevieve Fong; Abigail Vellajo; Nathan J J Martin; XiaoSuo Wang; Joanne M Dennis; Arpeeta Sharma; Waled A Shihata; Jaye P F Chin-Dusting; Judy B de Haan; Alexandra Sharland; Carolyn L Geczy; Ben Freedman; Paul K Witting
Journal:  Front Immunol       Date:  2019-03-07       Impact factor: 7.561

6.  Randomized clinical trial of the effect of intraoperative humidified carbon dioxide insufflation in open laparotomy for colorectal resection.

Authors:  J Y Cheong; B Chami; G M Fong; X S Wang; A Keshava; C J Young; P Witting
Journal:  BJS Open       Date:  2019-11-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.